title: c-Jun NH2 terminal kinase activation and decreased expression of mitogen-activated protein kinase phosphatase-1 play important roles in invasion and angiogenesis of urothelial carcinomas.
abstract: We here examined whether c-Jun NH(2) terminal kinase (JNK) might be involved in the progression of urothelial carcinomas. In vitro and in vivo invasion assays using Matrigel and chick embryo chorioallantoic membrane approaches showed constitutive activation of JNK to significantly increase two processes, invasion and angiogenesis, in the human urothelial carcinoma cell line kU-7, this being suppressed by a JNK inhibitor, SP600125, or cell-permeable peptides. In addition, we found that mitogen-activated protein kinase phosphatase (MKP)-1 functions as an endogenous inhibitor of JNK-mediated signals in urothelial carcinoma cells: chorioallantoic membrane assays showed UMUC14 cells with low MKP-1 expression to be more invasive and have pronounced angiogenesis compared to UMUC6 cells with high MKP-1. Furthermore, knockdown of the MKP-1 gene by siRNA transfection enhanced JNK activation in UMUC6 cells to the UMUC14 level. Immunohistochemically, JNK was found to be highly phosphorylated in high-grade and invasive carcinomas (>/=pT2) as well as carcinoma in situ but not in low-grade and noninvasive phenotypes (pTa, pT1). In contrast, MKP-1 was much more expressed in low-grade/noninvasive cancers than with the high-grade/invasive phenotype, reversely correlating with phosphorylated JNK. Taken together, JNK activation and decreased expression of MKP-1 may play important roles in progression of urothelial carcinoma.
authors: Department of Pathology, Nara Medical University School of Medicine, Shijo-cho, Kashihara city, Nara, 634-8521, Japan.
authors: Keiji
authors: K
authors: Shimada
authors: Mitsutoshi
authors: M
authors: Nakamura
authors: Eiwa
authors: E
authors: Ishida
authors: Tomonori
authors: T
authors: Higuchi
authors: Motoyoshi
authors: M
authors: Tanaka
authors: Ichiro
authors: I
authors: Ota
authors: Noboru
authors: N
authors: Konishi
mesh_terms: D000818:Animals; D045744:Cell Line, Tumor; D002642:Chick Embryo; D054638:Dual Specificity Phosphatase 1 / Q000235:genetics / Q000378:metabolism*; D004789:Enzyme Activation; D006801:Humans; D048031:JNK Mitogen-Activated Protein Kinases / Q000235:genetics / Q000378:metabolism*; D020935:MAP Kinase Signaling System / Q000502:physiology; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic; D034741:RNA, Small Interfering / Q000235:genetics / Q000378:metabolism; D014571:Urologic Neoplasms / Q000201:enzymology / Q000473:pathology / Q000503:physiopathology; D019459:Urothelium / Q000166:cytology / Q000201:enzymology / Q000473:pathology*
chemical_list: D034741:RNA, Small Interfering; D048031:JNK Mitogen-Activated Protein Kinases; D054638:Dual Specificity Phosphatase 1
references: J Cell Biol. 2004 Nov 22;167(4):769-81
references: 15557125
references: Leukemia. 2006 Oct;20(10):1759-66
references: 16932349
references: J Pharmacol Exp Ther. 2005 Apr;313(1):325-32
references: 15626722
references: J Biol Chem. 2005 Apr 22;280(16):16461-6
references: 15722358
references: J Pathol. 2005 Aug;206(4):423-32
references: 15906275
references: Oncogene. 2005 Aug 4;24(33):5218-25
references: 15897885
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: J Biol Chem. 2000 Jan 28;275(4):2390-8
references: 10644690
references: EMBO J. 2000 Jun 15;19(12):2911-23
references: 10856236
references: Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7272-7
references: 10852963
references: Cell. 2000 Oct 13;103(2):239-52
references: 11057897
references: Oncogene. 2000 Oct 26;19(45):5142-52
references: 11064451
references: Oncogene. 2000 Nov 9;19(47):5406-12
references: 11103942
references: Carcinogenesis. 2005 Sep;26(9):1553-62
references: 15860507
references: Nat Rev Cancer. 2005 Sep;5(9):713-25
references: 16110317
references: Int J Oncol. 2006 Jan;28(1):135-41
references: 16327989
references: Histol Histopathol. 2006 Apr;21(4):415-22
references: 16437387
references: Mol Cell Biol. 2006 Feb;26(4):1297-306
references: 16449643
references: Cancer. 2006 Mar 15;106(6):1205-16
references: 16470587
references: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3775-80
references: 16537454
references: Oncogene. 2006 Apr 20;25(17):2500-8
references: 16518417
references: Biochem Biophys Res Commun. 2006 Jun 16;344(4):1284-9
references: 16650813
references: Curr Biol. 2006 Jun 6;16(11):1139-46
references: 16753569
references: Oncogene. 2006 Aug 17;25(36):4998-5010
references: 16568086
references: Cancer Sci. 2006 Sep;97(9):821-8
references: 16822297
references: Cancer Res. 2006 Sep 1;66(17):8870-7
references: 16951204
references: J Biol Chem. 2000 Dec 15;275(50):38953-6
references: 11038347
references: Int J Cancer. 2001 Oct 15;94(2):153-6
references: 11668491
references: Am J Pathol. 2002 Apr;160(4):1207-14
references: 11943705
references: Jpn J Cancer Res. 2002 Oct;93(10):1164-74
references: 12417047
references: Br J Cancer. 2003 Apr 22;88(8):1223-8
references: 12698188
references: Prostate. 2003 Jun 1;55(4):265-80
references: 12712406
references: Carcinogenesis. 2003 Jun;24(6):1067-75
references: 12807754
references: EMBO J. 2003 Jul 1;22(13):3346-55
references: 12839996
references: Nature. 2003 Jul 10;424(6945):219-23
references: 12853963
references: J Urol. 2003 Sep;170(3):975-8
references: 12913753
references: J Cell Biol. 2003 Sep 1;162(5):933-43
references: 12952943
references: Nat Cell Biol. 2004 Feb;6(2):154-61
references: 14743221
references: Urol Oncol. 2004 Jan-Feb;22(1):1-6
references: 14969795
references: Cell Signal. 2004 Jul;16(7):769-79
references: 15115656
references: Clin Cancer Res. 2004 Jun 1;10(11):3639-49
references: 15173070
references: Carcinogenesis. 2004 Jul;25(7):1089-97
references: 15001534
references: EMBO J. 1985 Dec 1;4(12):3145-51
references: 3841511
references: Oncogene. 1992 Jan;7(1):187-90
references: 1741163
references: Urol Clin North Am. 1992 Nov;19(4):735-46
references: 1279877
references: Br J Urol. 1994 May;73(5):516-21
references: 8012773
references: J Natl Cancer Inst. 1995 Jan 18;87(2):129-33
references: 7707384
references: J Biol Chem. 1995 Apr 14;270(15):8377-80
references: 7721728
references: Oncogene. 1995 May 18;10(10):1895-904
references: 7761091
references: Urol Int. 1995;55(2):63-7
references: 8533197
references: Science. 1995 Nov 24;270(5240):1326-31
references: 7481820
references: Semin Urol Oncol. 1996 May;14(2):62-72
references: 8734733
references: Cell. 1996 Oct 18;87(2):159-70
references: 8861899
references: Am J Pathol. 1996 Nov;149(5):1553-64
references: 8909245
references: Lab Invest. 1997 Jan;76(1):37-51
references: 9010448
references: EMBO J. 1997 Aug 15;16(16):4961-72
references: 9305638
references: Cancer Res. 1998 Mar 1;58(5):1048-51
references: 9500469
references: Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3014-9
references: 9501207
references: Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1035-45
references: 9672063
references: Urol Res. 1998;26(6):371-6
references: 9879815
references: Exp Cell Res. 1999 Mar 15;247(2):495-504
references: 10066377
references: BJU Int. 2006 Nov;98(5):1090-3
references: 17034609
references: Cell Signal. 2005 Jun;17(6):769-75
references: 15722201